State-of-the-art Narrative Review: Multimodality Imaging in Electrophysiology and Cardiac Device Therapies

Overview

Journal Cardiovasc Diagn Ther

Publisher AME Publishing Company

Specialty Cardiology & Vascular Diseases

Date 2021 Jul 23

PMID 34295711

Authors

Balint Laczay

Divyang Patel

Richard Grimm

Bo Xu

Affiliations

Soon will be listed here.

Abstract

Cardiac electrophysiology procedures have evolved to provide improvement in morbidity and mortality for many patients. Cardiac resynchronization therapy (CRT), implantable cardioverter/defibrillator (ICD) placement and lead extraction procedures are proven procedures, associated with significant reductions in patient morbidity and mortality as well as improved quality of life. The applications and optimization of these therapies are an evolving field. The optimal use and outcomes of cardiac electrophysiology procedures require a multidisciplinary approach to patient selection, device selection, and procedural planning. Cardiac imaging using echocardiography plays a key role in selection of patients for CRT therapy, for guidance of left ventricular (LV) lead placement, and for optimization of atrioventricular pacing delays in patients with CRT. Cardiac computed tomography (CT) is an important tool in assessment of lead perforation, as well as assessing risk of lead extraction and procedural planning. Cardiac magnetic resonance imaging (MRI) is an important adjunct to transthoracic echocardiography for patient selection and risk stratification for defibrillator therapy for multiple disease states including ischemic cardiomyopathy, hypertrophic cardiomyopathy, cardiac sarcoidosis, and arrhythmogenic right ventricular cardiomyopathy (ARVC). Cardiac positron emission tomography (PET) is a useful adjunct to the diagnosis of device infections as well as inflammatory conditions including cardiac sarcoidosis. Our review attempts to summarize the contemporary roles of multimodality imaging in CRT therapy, ICD therapy and lead extraction therapy.

References

Marechaux S, Menet A, Guyomar Y, Ennezat P, Guerbaai R, Graux P . Role of echocardiography before cardiac resynchronization therapy: new advances and current developments. Echocardiography. 2016; 33(11):1745-1752. DOI: 10.1111/echo.13334. View

Yu C, Gorcsan 3rd J, Bleeker G, Zhang Q, Schalij M, Suffoletto M . Usefulness of tissue Doppler velocity and strain dyssynchrony for predicting left ventricular reverse remodeling response after cardiac resynchronization therapy. Am J Cardiol. 2007; 100(8):1263-70. DOI: 10.1016/j.amjcard.2007.05.060. View

Derval N, Steendijk P, Gula L, Deplagne A, Laborderie J, Sacher F . Optimizing hemodynamics in heart failure patients by systematic screening of left ventricular pacing sites: the lateral left ventricular wall and the coronary sinus are rarely the best sites. J Am Coll Cardiol. 2009; 55(6):566-75. DOI: 10.1016/j.jacc.2009.08.045. View

Ehieli W, Boll D, Marin D, Lewis R, Piccini J, Hurwitz L . Use of Preprocedural MDCT for Cardiac Implantable Electric Device Lead Extraction: Frequency of Findings That Change Management. AJR Am J Roentgenol. 2017; 208(4):770-776. DOI: 10.2214/AJR.16.16897. View

Chung E, Leon A, Tavazzi L, Sun J, Nihoyannopoulos P, Merlino J . Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation. 2008; 117(20):2608-16. DOI: 10.1161/CIRCULATIONAHA.107.743120. View

Skali H, Schulman A, Dorbala S . 18F-FDG PET/CT for the assessment of myocardial sarcoidosis. Curr Cardiol Rep. 2013; 15(4):352. PMC: 4009625. View

Baddour L, Epstein A, Erickson C, Knight B, Levison M, Lockhart P . Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010; 121(3):458-77. DOI: 10.1161/CIRCULATIONAHA.109.192665. View

Rudolph A, Abdel-Aty H, Bohl S, Boye P, Zagrosek A, Dietz R . Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol. 2009; 53(3):284-91. DOI: 10.1016/j.jacc.2008.08.064. View

Aggarwal N, Martinez M, Gersh B, Chareonthaitawee P . Role of cardiac MRI and nuclear imaging in cardiac resynchronization therapy. Nat Rev Cardiol. 2009; 6(12):759-70. DOI: 10.1038/nrcardio.2009.189. View

10.

Waggoner A, de las Fuentes L, Davila-Roman V . Doppler echocardiographic methods for optimization of the atrioventricular delay during cardiac resynchronization therapy. Echocardiography. 2008; 25(9):1047-55. PMC: 2649785. DOI: 10.1111/j.1540-8175.2008.00787.x. View

11.

Sood N, Martin D, Lampert R, Curtis J, Parzynski C, Clancy J . Incidence and Predictors of Perioperative Complications With Transvenous Lead Extractions: Real-World Experience With National Cardiovascular Data Registry. Circ Arrhythm Electrophysiol. 2018; 11(2):e004768. DOI: 10.1161/CIRCEP.116.004768. View

12.

Maron B, Shen W, Link M, EPSTEIN A, Almquist A, Daubert J . Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med. 2000; 342(6):365-73. DOI: 10.1056/NEJM200002103420601. View

13.

Zizek D, Cvijic M, Lezaic L, Guzic Salobir B, Zupan I . Impact of myocardial viability assessed by myocardial perfusion imaging on ventricular tachyarrhythmias in cardiac resynchronization therapy. J Nucl Cardiol. 2013; 20(6):1049-59. DOI: 10.1007/s12350-013-9795-y. View

14.

Sieniewicz B, Gould J, Porter B, Sidhu B, Teall T, Webb J . Understanding non-response to cardiac resynchronisation therapy: common problems and potential solutions. Heart Fail Rev. 2018; 24(1):41-54. PMC: 6313376. DOI: 10.1007/s10741-018-9734-8. View

15.

Segreti L, Cori A, Soldati E, Zucchelli G, Viani S, Paperini L . Major predictors of fibrous adherences in transvenous implantable cardioverter-defibrillator lead extraction. Heart Rhythm. 2014; 11(12):2196-201. DOI: 10.1016/j.hrthm.2014.08.011. View

16.

To A, Benatti R, Sato K, Grimm R, Thomas J, Wilkoff B . Strain-time curve analysis by speckle tracking echocardiography in cardiac resynchronization therapy: Insight into the pathophysiology of responders vs. non-responders. Cardiovasc Ultrasound. 2016; 14:14. PMC: 4835914. DOI: 10.1186/s12947-016-0057-4. View

17.

Yancy C, Jessup M, Bozkurt B, Butler J, Casey Jr D, Drazner M . 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013; 128(16):1810-52. DOI: 10.1161/CIR.0b013e31829e8807. View

18.

Buxton A, Lee K, DiCarlo L, Gold M, Greer G, Prystowsky E . Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 2000; 342(26):1937-45. DOI: 10.1056/NEJM200006293422602. View

19.

Ahmed F, James J, Cunnington C, Motwani M, Fullwood C, Hooper J . Early diagnosis of cardiac implantable electronic device generator pocket infection using ¹⁸F-FDG-PET/CT. Eur Heart J Cardiovasc Imaging. 2015; 16(5):521-30. PMC: 4407104. DOI: 10.1093/ehjci/jeu295. View

20.

Elliott P, Sharma S, Varnava A, Poloniecki J, Rowland E, McKenna W . Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1999; 33(6):1596-601. DOI: 10.1016/s0735-1097(99)00056-x. View